Tipsheet
What matters at India’s listed companies
Order Wins · Consumer Food · Micro cap

Mukka Proteins gets partial tax relief, ₹7.55 cr rate dispute remains

Income Tax appellate order deletes ₹3.60 cr and ₹4.48 cr in additions but sustains ₹7.55 cr. The contested 78% vs 34.944% tax rate could determine the final hit.

3 earlier stories on Mukka Proteins Ltd.
Mkt cap₹728 cr
P/E13.97×
ROE10.54%
Debt / eq.1.02
₹7.55 cr Sustained addition with disputed tax rate

What's new

  • Tax appellate partly allows appeal, deleting ₹3.60 cr excess stock and ₹4.48 cr prior period income additions.
  • Sustains ₹7.55 cr addition for excess stock; company had already paid tax at 34.944%.
  • Dispute: whether the sustained amount is taxed at 78% special rate or normal rate; final impact depends on further steps.

Why this matters

The order removes some contingent liabilities but leaves a ₹7.55 cr exposure with a potential 78% tax rate. However, the incremental tax is modest relative to Mukka's ₹714 cr market cap, so the investment thesis remains intact.

What we're watching

  • Whether the company appeals the sustained addition and the rate application.
  • Any adjustments to tax provisions in upcoming quarterly results.
  • Broader working capital cycle and credit rating, given prior CARE downgrade.

The full read

Mukka Proteins received a mixed tax appeal order for assessment year 2018-19. The Commissioner of Income Tax (Appeals) deleted additions of ₹3.60 crore for alleged excess stock and ₹4.48 crore for prior period income, but sustained ₹7.55 crore for excess stock. The dispute now centers on whether that ₹7.55 crore should be taxed at a punitive 78% under section 115BBE or the normal 34.944% the company already paid. The incremental tax, though uncertain, is modest relative to Mukka's ₹714 crore market cap and likely net worth. The company is evaluating its legal options. For now, the order removes some contingent liabilities but leaves a manageable uncertainty.

Questions answered

What did the Income Tax appellate order decide for Mukka Proteins?
The Commissioner of Income Tax (Appeals) partly allowed Mukka's appeal for AY 2018-19, deleting additions of ₹3.60 crore (excess stock) and ₹4.48 crore (prior period income), but sustaining ₹7.55 crore for excess stock. The sustained amount faces a disputed tax rate of 78% vs 34.944% already paid.
What is the potential financial impact of the sustained addition?
The incremental tax depends on the applicable rate: 78% under section 115BBE or the normal 34.944% already paid. The impact is modest relative to Mukka's ₹714 crore market cap, below materiality thresholds.
Why was the prior period income addition deleted?
The appellate authority accepted that the prior period income had already been taxed in earlier years, so adding it again would result in double taxation.
What are the company's next steps regarding this tax order?
Mukka is evaluating further legal steps. It may appeal the sustained addition or challenge the applicable tax rate at higher appellate forums.
Does this tax order affect Mukka's financial statements immediately?
Not immediately. The company has already paid tax at 34.944% on the sustained amount. Any incremental liability depends on the final outcome of the rate dispute, which could take years.
Mentioned: Commissioner of Income Tax (Appeals)-2, Panaji · ₹7.55 cr · Section 115BBE
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Mukka Proteins Ltd.

FMCG
₹730 cr
P/E 14.03×

Latest quarter · Mar 2026

Sales₹381 cr
Net profit₹21 cr
Op. margin+8.9%
EPS₹0.69

Strength & growth

Debt / equity1.02×
Current ratio1.52×
Financials via Tijori — a research aid, not investment advice.MUKKA on Tijori

Story so far

All notes on MUKKA →
  1. 1 Jul 2026 · 5:13 PM IST Mukka Proteins gets partial tax relief, ₹7.55 cr rate dispute remains
  2. 24d ago Mukka Proteins raises ₹47 cr via warrants, buys two fish meal firms for ₹26 cr
  3. 27d ago Mukka Proteins board to meet on June 12 for equity fundraise after credit downgrade
  4. 41d ago CARE Ratings cuts Mukka Proteins' credit rating on liquidity stress